These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis. Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234 [TBL] [Abstract][Full Text] [Related]
4. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis. Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083 [TBL] [Abstract][Full Text] [Related]
5. Is Extensive Parenchymal Resection During Robotic Partial Nephrectomy Justified? A Match-Paired Comparison of Two Extirpative Surgical Modalities for Treatment of a Complex Renal Neoplasm. Andrade HS; Zargar H; Akca O; Caputo PA; Ramirez D; Kara O; Stein RJ; Chueh SC; Kaouk JH J Endourol; 2016 Apr; 30(4):379-83. PubMed ID: 26486995 [TBL] [Abstract][Full Text] [Related]
6. Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group. Bradshaw AW; Autorino R; Simone G; Yang B; Uzzo RG; Porpiglia F; Capitanio U; Porter J; Bertolo R; Minervini A; Lau C; Jacobsohn K; Ashrafi A; Eun D; Mottrie A; White WM; Schips L; Challacombe BJ; De Cobelli O; Mir CM; Veccia A; Larcher A; Kutikov A; Aron M; Dasgupta P; Montorsi F; Gill IS; Sundaram CP; Kaouk J; Derweesh IH BJU Int; 2020 Jul; 126(1):114-123. PubMed ID: 32232920 [TBL] [Abstract][Full Text] [Related]
7. Oncological outcomes of patients with incidental pathological T3a stage small renal cell carcinoma after partial nephrectomy. Lee C; You D; Yoo S; Song C; Hong B; Hong JH; Ahn H; Kim CS J Cancer Res Clin Oncol; 2016 Jul; 142(7):1651-7. PubMed ID: 27193144 [TBL] [Abstract][Full Text] [Related]
8. Percutaneous Radiofrequency Ablation Versus Robotic-Assisted Partial Nephrectomy for the Treatment of Small Renal Cell Carcinoma. Pantelidou M; Challacombe B; McGrath A; Brown M; Ilyas S; Katsanos K; Adam A Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1595-1603. PubMed ID: 27435582 [TBL] [Abstract][Full Text] [Related]
9. Multi-institutional Survival Analysis of Incidental Pathologic T3a Upstaging in Clinical T1 Renal Cell Carcinoma Following Partial Nephrectomy. Russell CM; Lebastchi AH; Chipollini J; Niemann A; Mehra R; Morgan TM; Miller DC; Palapattu GS; Hafez KS; Sexton WJ; Spiess PE; Weizer AZ Urology; 2018 Jul; 117():95-100. PubMed ID: 29678662 [TBL] [Abstract][Full Text] [Related]
10. Robotic and open partial nephrectomy for complex renal tumors: a matched-pair comparison with a long-term follow-up. Wang Y; Shao J; Ma X; Du Q; Gong H; Zhang X World J Urol; 2017 Jan; 35(1):73-80. PubMed ID: 27194142 [TBL] [Abstract][Full Text] [Related]
11. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Lau WK; Blute ML; Weaver AL; Torres VE; Zincke H Mayo Clin Proc; 2000 Dec; 75(12):1236-42. PubMed ID: 11126830 [TBL] [Abstract][Full Text] [Related]
12. Outcomes of open versus robotic partial nephrectomy: a 20-year single institution experience. Love H; Yong C; Slaven JE; Mahenthiran AK; Roper C; Black M; Zhang W; Patrick E; DeMichael K; Wesson T; O'Brien S; Farrell R; Gardner T; Masterson TA; Boris RS; Sundaram CP J Robot Surg; 2024 Aug; 18(1):315. PubMed ID: 39115647 [TBL] [Abstract][Full Text] [Related]
13. Long-term oncological outcomes after robotic partial nephrectomy for renal cell carcinoma: a prospective multicentre study. Beauval JB; Peyronnet B; Benoit T; Cabarrou B; Seisen T; Roumiguié M; Pradere B; Khene ZE; Manach Q; Verhoest G; Thoulouzan M; Parra J; Doumerc N; Mathieu R; Vaessen C; Soulié M; Roupret M; Bensalah K World J Urol; 2018 Jun; 36(6):897-904. PubMed ID: 29427002 [TBL] [Abstract][Full Text] [Related]
14. Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma. Sugiyama Y; Yatsuda J; Murakami Y; Ito N; Yamasaki T; Mikami Y; Ogawa O; Kamba T Jpn J Clin Oncol; 2019 May; 49(5):465-472. PubMed ID: 30793163 [TBL] [Abstract][Full Text] [Related]
15. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy? Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867 [TBL] [Abstract][Full Text] [Related]
16. Robotic partial nephrectomy versus radical nephrectomy in elderly patients with large renal masses. Veccia A; Dell'oglio P; Antonelli A; Minervini A; Simone G; Challacombe B; Perdonà S; Porter J; Zhang C; Capitanio U; Sundaram CP; Cacciamani G; Aron M; Anele U; Hampton LJ; Simeone C; De Naeyer G; Bradshawh A; Mari A; Campi R; Carini M; Fiori C; Gallucci M; Jacobsohn K; Eun D; Lau C; Kaouk J; Derweesh I; Porpiglia F; Mottrie A; Autorino R Minerva Urol Nefrol; 2020 Feb; 72(1):99-108. PubMed ID: 31527571 [TBL] [Abstract][Full Text] [Related]
17. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis. O'Malley RL; Hayn MH; Brewer KA; Underwood W; Hellenthal NJ; Kim HL; Sorokin I; Schwaab T World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189 [TBL] [Abstract][Full Text] [Related]
18. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy. Liu S; Feng C; Liu C; Wang Z Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154 [TBL] [Abstract][Full Text] [Related]
19. Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer. Shvero A; Nativ O; Abu-Ghanem Y; Zilberman D; Zaher B; Levitt M; Fridman E; Portnoy O; Ramon J; Dotan ZA Clin Genitourin Cancer; 2018 Jun; 16(3):e613-e617. PubMed ID: 29174471 [TBL] [Abstract][Full Text] [Related]
20. Minimally invasive nephron-sparing treatments for T1 renal cell cancer in patients over 75 years: a comparison of outcomes after robot-assisted partial nephrectomy and percutaneous ablation. Lehrer R; Cornelis F; Bernhard JC; Bigot P; Champy C; Bruyère F; Rouprêt M; Doumerc N; Bensalah CK; Olivier J; Audenet F; Tricard T; Parier B; Durand X; Durand M; Charles T; Branger N; Surlemont L; Xylinas E; Beauval JB; Barral M Eur Radiol; 2023 Dec; 33(12):8426-8435. PubMed ID: 37466710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]